KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Retained Earnings: 2009-2024

Historic Retained Earnings for Novavax (NVAX) over the last 16 years, with Dec 2024 value amounting to -$5.0 billion.

  • Novavax's Retained Earnings rose 6.94% to -$4.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 billion, marking a year-over-year increase of 6.94%. This contributed to the annual value of -$5.0 billion for FY2024, which is 3.89% down from last year.
  • Latest data reveals that Novavax reported Retained Earnings of -$5.0 billion as of FY2024, which was down 3.89% from -$4.8 billion recorded in FY2023.
  • In the past 5 years, Novavax's Retained Earnings registered a high of -$1.9 billion during FY2020, and its lowest value of -$5.0 billion during FY2024.
  • Its 3-year average for Retained Earnings is -$4.7 billion, with a median of -$4.8 billion in 2023.
  • Data for Novavax's Retained Earnings shows a maximum YoY plummeted of 93.04% (in 2021) over the last 5 years.
  • Over the past 5 years, Novavax's Retained Earnings (Yearly) stood at -$1.9 billion in 2020, then slumped by 93.04% to -$3.6 billion in 2021, then declined by 18.19% to -$4.3 billion in 2022, then declined by 12.75% to -$4.8 billion in 2023, then decreased by 3.89% to -$5.0 billion in 2024.